SCHEMBL7416274

SCHEMBL7416274

COc1ccc(C=CCC2CCCCN2C(=O)OC(C)(C)C)cc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.46
ALDH1A1 P00352 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
LMNA P02545 1/20 0.43
TSHR P16473 1/20 0.43
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KDM1A O60341 1/20 0.41
PDE8B O95263 1/20 0.41
TRPM8 Q7Z2W7 1/20 0.41
HRH3 Q9Y5N1 2/20 0.40
STS P08842 1/20 0.40
CHEK2 O96017 1/20 0.40
HTT P42858 1/20 0.40
GPR119 Q8TDV5 1/20 0.39
MAOB P27338 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7416272 1.00 PTGS2 (0.46) PTGS2ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL7415474 0.89 KMT2A (0.44) ALDH1A1L3MBTL1MEN1KMT2ALMNA
SCHEMBL7415471 0.89 KMT2A (0.44) ALDH1A1L3MBTL1MEN1KMT2ALMNA
SCHEMBL7417755 0.88 HRH3 (0.47) ALDH1A1L3MBTL1MEN1KMT2ALMNA
SCHEMBL7421448 0.88 ALDH1A1 (0.44) ALDH1A1L3MBTL1MEN1KMT2ALMNA
SCHEMBL7421452 0.88 ALDH1A1 (0.44) ALDH1A1L3MBTL1MEN1KMT2ALMNA
SCHEMBL7417752 0.88 HRH3 (0.47) ALDH1A1L3MBTL1MEN1KMT2ALMNA
SCHEMBL7417065 0.88 MEN1 (0.54) ALDH1A1L3MBTL1MEN1KMT2ALMNA
SCHEMBL7816624 0.88 MEN1 (0.54) ALDH1A1L3MBTL1MEN1KMT2ALMNA
SCHEMBL7415661 0.86 HRH3 (0.51) ALDH1A1L3MBTL1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0734379-B1 2-ARYLALKENYL-AZACYCLOALKANE DERIVATIVES AS SIGMA RECEPTOR LIGANDS, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF PARKE DAVIS (FR) 2001-03-07 EP disclosed
EP-0995436-A2 Ligands for sigma receptors and their therapeutical applications PARKE-DAVIS (FR) 2000-04-26 EP disclosed
US-6013656-A PSYCHOLOGICAL DISORDERS; GASTROINTESTINAL DISORDERS; NERVOUSSYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 2000-01-11 US disclosed
US-5849760-A 2-(arylalkenyl)azacycloalkane derivatives as ligands for sigma receptors INSTITUT DE RECHERCHE JOUVEINAL (FR) 1998-12-15 US disclosed
WO-1995015948-A1 NOVEL 2-ARYLALKENYL-AZACYCLOALKANE DERIVATIVES AS SIGMA RECEPTOR LIGANDS, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF INSTITUT DE RECHERCHE JOUVEINAL (FR) 1995-06-15 WO disclosed